Advertisement

Topics

Companies Related to "Hemostasis in Sickle Cell Disease--Infancy to Adulthood" [Most Relevant Company Matches] - Page: 3 RSS

07:46 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Hemostasis in Sickle Cell Disease--Infancy to Adulthood" found in our extensive corporate database of over 50,000 company records.

Showing "Hemostasis Sickle Cell Disease Infancy Adulthood" Companies 51–75 of 3,800+

Relevant

Celldom, Inc.

Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company’s TrapTx Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to 100,000s of cells per experiment) to identify a...


LFB S.A.

LFB S.A. (www.lfb.fr) is a multinational biopharmaceutical company that develops, manufactures, and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, including Hemostasis, Immunology and Intensive Care.

Probably Relevant

Milestones Autism Organization

Milestones, a Cleveland based 501(c)(3) organization, promotes lifelong strategies of success for individuals with autism, childhood through adulthood. Milestones conducts an annual conference; family workshops; and training; provides referral advice; and maintains a robust up-to-date website of autism information including services, programs and individual rights. Since its founding in 2003, Mile...


Nature Cell

Nature Cell (KOSDAQ: 007390) is a high-tech bio enterprise that runs Stem Cells business. The company has exclusive rights for business of products developed by Biostar Stem Cell Research Institute. More information about Nature Cell can be found at www.naturecell.co.kr.

OptiCell Inc.

OptiCell is a new concept in cell culture devices that revolutionizes the cell culture process.OptiCell accommodates the full range of cellculture activities from cell growth and magnetic cell separation to transfection in a device with the footprint of a standard microtiter plate.OptiCell can also be used for the production of monoclonal antibodies, cytokines, and other secreted molecules.

Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(TM)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that inc...

Amorcyte, Inc.

Amorcyte is a privately held biotechnology company developing cell therapy products to treat cardiovascular disease. Its lead product AMR-001, for the prevention of major adverse cardiac events following acute myocardial infarction (AMI), has completed Phase I clinical trials demonstrating feasibility, safety and biologic activity at a threshold dose. This is the first stem cell trial in AMI eve...

Medinox

Medinox, Inc. is a San Diego-based emerging pharmaceutical company that is developing new small molecule drugs of large revenue potential and tremendous scope. Our goal is to become a premier pharmaceutical company by commercializing new medicines for inflammatory diseases and disorders that save lives and improve the quality of life. To achieve this, we are developing three core pharmaceutical te...

Automated Cell, Inc

Automated Cell, Inc is focused on the discovery and development of monoclonal antibody therapeutics for the treatment of cancer. Our unique and proprietary technology allows us to rapidly and inexpensively identify human antibodies that have relevant biological function in a specific disease. Our approach is target-independent and does not require prior knowledge of the target or mechanism. We ant...

Maxygen

Maxygen is focused on the development of superior versions of validated major protein pharmaceuticals for the patients who need them. Our lead product candidates address substantial market opportunities in infectious disease, hemostasis and cancer. We are well positioned for growth with a number of excellent product candidates and the financial strength to drive them forward through clinical dev...

Anida Pharma, Inc.

Anida is a biopharmaceutical company developing novel first-in-class therapies to treat Parkinson’s disease, amyotrophic lateral sclerosis (ALS; Lou Gehrig disease), other central nervous system disorders, and hearing loss. Our therapeutic concept is based on activating the body’s own homeostatic mechanisms to regulate inflammation, prevent ...

CytoReason

Born out of 10 years’ research from Stanford and the Technion, CytoReason is the only AI company to focus entirely on the immune system in developing its proprietary data and AI / machine-learning approach. This approach is capable of constructing 3-dimensional maps of previously hidden, immune-system relationships at a cellular, tissue and disease le...

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers genetic profiling services and consultation, adult stem cell research, and stem cell collection, processing, and cryogenic storage, as well as cosmetic and other infusion therapies....

The Immune Response Corporation

The Immune Response Corporation (OTCBB: IMNR.OB) is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company’s lead immune-based therapeutic product candidates are NeuroVax™ for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimula...

Creative Medical Technologies

Creative Medical Technologies, Inc. (CMT) and its affiliate Creative Medical Health, Inc. (CMH) are clinical stage biotechnology companies specializing in cutting edge stem cell technology in the areas of urology, cardiovascular disease, orthopedics and type 2 diabetes. In addition to their work with LA BioMed, CMH and CMT have ongoing relationships with s...

BioSeek, Inc

BioSeek is committed to improving the success rate of pharmaceutical development by integrating human biology from the early stages of drug discovery through preclinical development. Our BioMAP® systems incorporate predictive human cell-based disease models that generate uniquely informative biological activity signatures for each potential drug, yielding actionable data to drive the selection a...

ScienCell Research Laboratories

ScienCell Research Laboratories (ScienCell) is a biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. The ScienCell technology provides a variety of high quality normal human and animal cells, cell culture media and reagents, medium supplements, cell-derived RNA, cDNA and proteins for the research community. Sci...

Cell Medica

Cell Medica is a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer. The Company’s lead clinical application, referred to as Virus-Specific Immune Reconstitution (VSIR), involves the transfer of donor-derived virus-specific T cells into a...

Genea Stem Cells Pty Ltd

Genea Biocells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Biocells Pty Ltd is governed by the same strong ethical principles and corporate governance practices. Genea Biocells is located in Sydney, Australia and has been supplying commercial stem cell solutions for several...

Z-Medica Corporation

Z-Medica Corporation is a medical device company developing innovative hemostatic agents. The company manufactures and markets its QuikClot® family of products for hemostasis for use by health care professionals, first responders, law enforcement officers and the military. QuikClot® products rapidly enhance the body’s natural coagulation process, helpi...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

ChondroGene

ChondroGene is a genomics-based company focused on the discovery and development of disease-specific therapeutic and diagnostic approaches, specializing in osteoarthritis. The Company has constructed the first known human cartilage-specific microarray, the ChondroChip™, and is continuing to characterize the gene expression of novel and known genes of the human cartilage cell in both health and d...

Genea Stem Cells Pty Ltd

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty Ltd is governed by the same strong ethical principles and corporate governance practices. Genea Stem Cells is located in Sydney, Australia and has been supplying commercial stem cell solutions for s...

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cancers related to oncogenic viruses. The Company’s lead cell product, CytovirTM CMV, for the treatment and prevention of cytomegalovirus (CMV) infections in patients following al...

Brainstorm Cell Therapeutics

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) and Multiple Sclerosis (MS). The adu...


More From BioPortfolio on "Hemostasis in Sickle Cell Disease--Infancy to Adulthood"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks